Karolinska Institutet study analyzed 7,308 patients with atrial fibrillation and Alzheimer’s.
Participants were grouped to NOACs, warfarin, or no anticoagulant treatment.
NOACs slowed MMSE decline by about 0.2 points per year versus others.
NOACs also linked to lower risks of death, stroke, clots, and fractures.
Study notes observational design and cannot prove causation; potential confounders exist.
Why it matters.NOACs were also associated with lower risks of death, stroke, clots, and fractures among patients with atrial fibrillation and Alzheimer’s.
What to watch.The observational study cannot prove causation, so further research should assess potential confounders and whether NOACs directly slow cognitive decline.
“Newer blood thinners may do more than prevent strokes in people with Alzheimer’s disease and atrial fibrillation. Researchers found that patients taking NOACs experienced a slower decline in cognitive function than those using warfarin or no blood thinners.”
SourceScienceDailyUnited StatesLeanCenterCredibilityRatings: AllSides, MBFCRead at ScienceDaily
“Newer blood thinners may do more than prevent strokes in people with Alzheimer’s disease and atrial fibrillation. Researchers found that patients taking NOACs experienced a slower decline in cognitive function than those using warfarin or no blood thinners.”
AI wrote this story from the reports above. No person checked it before it was published. How concise.news works
Why it’s in the Brief
Ranked 10th of 10.
Starting score
5.0
Public-interest topic
+1.0
Public-interest terms in the text
+1.25
High-reliability sources
+0.75
Score
8.0
The ranking is the same for everyone.
Perspective mix.1 center.RatingsAllSides and Media Bias/Fact CheckLean and credibility are curated from their public ratings.Unknown outlets stay unrated, never guessed.